Described is a low-grade fibromyxoid sarcoma (LGFMS) of the abdominal wall muscles in a 38-year-old black woman. There was no evidence of metastatic disease. A 5.2-kg LGFMS – the largest case ever reported – was resected. One year after surgery, the patient is alive without any sign of local recurrence or distant metastasis. Follow-up comprises abdominal and thoracic CT scans at 6-month intervals.

1.
Evans HL: Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol 1987;88:615–619.
2.
Goodlad JR, Mentzel T, Fletcher CDM: Low-grade fibromyxoid sarcoma: Clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology 1995;26:229–237.
3.
Masaharu F, Shinichiro U, Noboru F: Low-grade fibromyxoid sarcoma. Virchows Arch 1996;429:301–303.
4.
Evans HL: Low-grade fibromyxoid sarcoma: A report of 12 cases. Am J Surg Pathol 1993;17:595–600.
5.
Nichols GE, Cooper PH: Low-grade fibromyxoid sarcoma: Case report and immunohistochemical study. J Cutan Pathol 1994;21:356–362.
6.
Canpolat C, Evans HL, Corpron C, Andrassy RJ, Chan K, Eifel P, Elidemir O, Raney B: Fibromyxoid sarcoma in a four-year-old child: Case report and review of the literature. Med Pediatr Oncol 1996;27:561–564.
7.
Lindberg GM, Mastra A, Gokaslan ST, Saboorian MH, Albores Saavedra J: Low grade fibromyxoid sarcoma: Fine-needle aspiration cytology with histologic, cytogenetic, immunohistochemical and ultrastructural correlation. Cancer 1999;87:75–82.
8.
Shidham VB, Ayala GE, Lahaniatis JE, Garcia FU: Low-grade fibromycoid sarcoma: Clinicopathologic case report with review of the literature. Am J Clin Oncol 1999;22:150–155.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.